+1 (202) 780-3397
Opinion Article - Journal of Food Nutrition and Health (2024) Volume 7, Issue 2
Future treatment opportunities based on food allergy pathogenesis
Elwira Gliwska *
Department of Human Nutrition and Health, Gelderse Vallei Hospital, Wageningen University and Research, Wageningen, The Netherlands
- *Corresponding Author:
- Elwira Gliwska
Department of Human Nutrition and Health
Gelderse Vallei Hospital, Wageningen University and Research
Wageningen, The Netherlands
E-mail: elwira@gliwska.nl
Received: 27-Mar-2024, Manuscript No. AAJFNH-24-135373; Editor assigned: 30-Mar-2024, PreQC No. AAJFNH-24-135373(PQ); Reviewed:14-Apr-2024, QC No. AAJFNH-24-135373; Revised:22-Apr-2024, Manuscript No. AAJFNH-24-135373(R); Published: 29-Apr-2023, DOI:10.35841/ aajfnh-7.2.204
Citation: Gliwska E. Food allergy severity, Anaphylaxis, and healthcare utilization. J Food Nutr Health. 2024;7(2):204
Introduction
Food allergies have become a global health concern in recent years, affecting millions of individuals worldwide. While the prevalence of food allergies continues to rise, so does our understanding of the underlying pathogenesis. This increased knowledge has paved the way for exciting future treatment opportunities that may revolutionize the management of food allergies. In this article, we will explore the emerging treatment strategies based on food allergy pathogenesis, offering hope for those who suffer from these potentially life-threatening conditions [1].
To develop effective treatments for food allergies, it is crucial to comprehend the underlying pathogenesis. Food allergies occur when the immune system mistakenly identifies a specific food protein as harmful and mounts an immune response against it. This response involves the release of various inflammatory mediators, including histamine, which leads to allergic symptoms such as hives, swelling, difficulty breathing, and, in severe cases, anaphylaxis.
Genetic Predisposition: Genetics plays a significant role in determining an individual's susceptibility to food allergies. Research has identified specific genetic markers associated with an increased risk of developing food allergies [2].
Gut Microbiota: Emerging evidence suggests that the composition of gut microbiota may influence the development of food allergies. A balanced gut microbiome is essential for immune system regulation, and dysbiosis (an imbalance) may contribute to allergic sensitization.
Immune Dysregulation: Food allergy pathogenesis involves an abnormal immune response, with a predominant role played by T-helper 2 (Th2) cells. These cells release cytokines that promote inflammation and allergic reactions.
Epithelial Barrier Dysfunction: The epithelial cells lining the digestive tract act as a physical barrier to allergens. When this barrier is compromised, it becomes easier for allergens to cross into the bloodstream and trigger an immune response [3].
Recent advancements in our understanding of food allergy pathogenesis have opened up exciting treatment avenues. Here are some of the future treatment opportunities that hold promise:
Immunotherapy: Immunotherapy is a groundbreaking approach that aims to desensitize individuals to food allergens gradually. It involves exposing patients to tiny, controlled amounts of the allergen to build up tolerance over time. This can be achieved through various methods, including oral immunotherapy (OIT), sublingual immunotherapy (SLIT), and epicutaneous immunotherapy (EPIT). Clinical trials and research are ongoing to refine these approaches and make them safer and more effective [4].
Precision Medicine: Personalized treatment plans based on an individual's genetic profile may become a reality in the future. Identifying specific genetic markers associated with food allergies can help tailor therapies and predict treatment responses.
Microbiome Modulation: Manipulating the gut microbiota through probiotics, prebiotics, and fecal microbiota transplantation (FMT) holds potential for preventing and treating food allergies. Restoring a balanced gut microbiome may help regulate the immune system and reduce allergic sensitization. Barrier Enhancement: Strengthening the epithelial barrier of the gastrointestinal tract could prevent allergen penetration and reduce the risk of sensitization. Research into barrier-enhancing therapies is ongoing, with the development of targeted medications and dietary interventions [5].
Biologics: Monoclonal antibodies and other biologic drugs that target specific immune pathways involved in food allergy pathogenesis are being explored. These medications have shown promise in reducing allergic reactions and may become an integral part of food allergy management.
Epigenetic Modifications: Understanding epigenetic changes associated with food allergies may lead to novel therapeutic approaches. Epigenetic modifications can influence gene expression and immune responses, offering potential targets for intervention [6].
While the future treatment opportunities based on food allergy pathogenesis are promising, several challenges and considerations must be addressed:
Safety: Safety remains a paramount concern, especially in immunotherapy. Balancing the benefits of desensitization with the risk of adverse reactions is a delicate task.
Accessibility: Ensuring that emerging treatments are accessible and affordable to all individuals with food allergies is crucial to improving outcomes on a global scale.
Long-Term Effects: Understanding the long-term effects of new treatments is essential. Researchers need to assess not only short-term desensitization but also the durability of the response over time.
Early Intervention: Identifying food allergies early in life and intervening promptly may be key to successful treatment. Research into early diagnostic tools and strategies is essential.
Regulatory Approval: Many of these emerging treatments are still in the experimental stage and require regulatory approval. This process can be lengthy and complex [7].
The future of food allergy treatment is promising, thanks to our growing understanding of the underlying pathogenesis. Emerging treatment opportunities, such as immunotherapy, precision medicine, microbiome modulation, and barrier enhancement, offer hope for individuals living with food allergies. However, it is essential to address safety concerns, improve accessibility, and conduct further research to ensure the effectiveness and long-term benefits of these therapies. As the field of food allergy research continues to advance, we move closer to a future where food allergies are more manageable, and individuals can enjoy a safer and less restrictive diet [8,10].
References
- Wu G. Functional amino acids in nutrition and health. Amino acids. 2013;45:407-11.
- Miyajima M. Amino acids: Key sources for immunometabolites and immunotransmitters. Int Immunol. 2020;32(7):435-46.
- Hole?ek M. Side effects of amino acid supplements. Physiol Res. 2022;71(1):29.
- Zahradní?ková H, Opekar S, ?imná?ová L, et al. Chiral secondary amino acids, their importance, and methods of analysis. Amino Acids. 2022;54(5):687-719.
- Narancic T, Almahboub SA, O’Connor KE. Unnatural amino acids: Production and biotechnological potential. World J Microbiol Biotechnol. 2019;35:1-1.
- Pearlman M, Obert J, Casey L. The association between artificial sweeteners and obesity. Curr Gastroenterol Rep. 2017;19:1-8.
- Debras C, Chazelas E, Srour B, et al. Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. PLoS medicine. 2022;19(3):e1003950.
- Suez J, Korem T, Zilberman-Schapira G, et al. Non-caloric artificial sweeteners and the microbiome: Findings and challenges. Gut micro. 2015;6(2):149-55.
- Mooradian AD, Smith M, Tokuda M. The role of artificial and natural sweeteners in reducing the consumption of table sugar: A narrative review. Clin Nutr ESPEN. 2017;18:1-8.
- Suez J, Cohen Y, Valdés-Mas R, et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell. 2022;185(18):3307-28.